In 2019, Penn State Cancer Institute was the first hospital in central Pennsylvania to offer chimeric antigen receptor (CAR) T-cell therapy, a powerful, new treatment that harnesses the power of the immune system to fight cancer. Here’s a look at how CAR T-cell therapy works.

свернуть